Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Re-treatment with rituximab in rheumatoid arthritis patients from FIRST trial (ML19070)
2006-006746-33Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Primary endpoint: Change in DAS28 after first rituximab re-treatment. Started Mar 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-006746-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006746-33.